ALGOQUANTBSEALGOQUANT FINTECH LIMITEDMediumNeutral
Announced Wed, 14 Oct, 2026 · 19:01 IST

Algoquant invests Rs 52.5L in subsidiary AQCSPL via Rights Issue

Listed Co AcquisitionStrategic Transactions View source PDFExplain this filing

ALGOQUANT · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.2%Reaction day
₹71.82
prior close
₹71.44
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.6%-0.6% vs market
Stockbroking & Allied peers, median of 39sector-0.2%-2.1% vs sector

On the reaction day the stock moved 0.6 pts less than Nifty Microcap 250 and 2.1 pts less than its Stockbroking & Allied peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.2
10m
-0.7
15m
+0.4
30m
+0.7
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.2-1.6-0.6-0.2-2.1
Next day
+1.3-1.0+2.2-0.6+1.9
2d
+1.7-2.6+4.3-1.8+3.5
3d
+0.6-5.1+5.8-3.8+4.4
4d
+3.5-6.1+9.6-4.7+8.2
5d
+4.7-8.3+13.0-6.0+10.7
1w
+6.2-6.4+12.5-5.7+11.9
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Stockbroking & Allied peers, median of 39Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Algoquant Fintech invested Rs 52.5 lakh in its subsidiary AQ Capital Services (AQCSPL) by subscribing to its Rights Issue. It was allotted 52,500 shares at Rs 100 each (Rs 10 face value plus Rs 90 premium). Shareholding in AQCSPL remains unchanged at 75 percent, so it continues as a subsidiary. AQCSPL plans to act as a Registrar and Transfer Agent and is pursuing SEBI registration but has not started operations yet. The funds will be used for SEBI registration and running costs.

Likely market impact

Minor capital infusion into subsidiary AQCSPL for its RTA business. No change in parent shareholding. Limited stock impact.